Related Experiment Video
Updated: Aug 8, 2026

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
Published on: July 29, 2014
Inhibitory sequences in the N-terminus of the double-stranded-RNA-dependent protein kinase, PKR, are important for
K M Vattem1, K A Staschke, S Zhu
1Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
Abstract:
During viral infection, phosphorylation of the alpha subunit of eukaryotic initiation factor 2 (eIF2alpha) by the interferon-induced RNA-dependent protein kinase, PKR, leads to inhibition of translation initiation and viral proliferation. Activation of PKR is mediated by association of virally encoded double-stranded RNAs (dsRNAs) with two dsRNA binding domains (dsRBDs) located in the N-terminus of PKR. To better understand the molecular mechanisms regulating PKR, we characterized the activities of wild-type and mutant versions of human PKR expressed and purified from yeast. The catalytic rate of eIF2alpha phosphorylation by our purified PKR was increased in response to dsRNA, but not single-stranded RNA or DNA, consistent with the properties previously described for PKR purified from mammalian sources. While both dsRBD1 and dsRBD2 were required for activation of PKR by dsRNA, only deletion of dsRBD1 severely reduced the basal eIF2alpha kinase activity. Removal of as few as 25 residues at the C-terminal junction of dsRBD2 dramatically increased eIF2alpha kinase activity and characterization of larger deletions that included dsRBD1 demonstrated that removal of these negative-acting sequences could bypass the dsRBD1 requirement for in vitro phosphorylation of eIF2alpha. Heparin, a known in vitro activator of PKR, enhanced eIF2alpha phosphorylation by PKR mutants lacking their entire N-terminal sequences, including the dsRBDs. The results indicate that induction of PKR activity is mediated by multiple mechanisms, one of which involves release of inhibition by negative-acting sequences in PKR.
Insights
The RNA-dependent protein kinase, PKR, regulates viral infection by phosphorylating eIF2alpha. Negative-acting sequences within PKR
Area of Science:
- Molecular Biology
- Virology
- Biochemistry
Background:
- The interferon-induced RNA-dependent protein kinase (PKR) inhibits viral proliferation by phosphorylating eukaryotic initiation factor 2 alpha (eIF2alpha).
- PKR activation is triggered by viral double-stranded RNAs (dsRNAs) binding to its N-terminal dsRNA binding domains (dsRBDs).
Purpose of the Study:
- To investigate the molecular mechanisms regulating human PKR activity.
- To characterize the roles of PKR's dsRNA binding domains (dsRBDs) and other regulatory regions in kinase activity.
Main Methods:
- Expression and purification of wild-type and mutant human PKR from yeast.
- In vitro kinase assays measuring eIF2alpha phosphorylation in response to dsRNA, single-stranded RNA, and DNA.
- Analysis of PKR mutants with deletions in dsRBDs and C-terminal regions.
Main Results:
- Purified PKR phosphorylated eIF2alpha in response to dsRNA but not other nucleic acids.
- Both dsRBD1 and dsRBD2 were necessary for dsRNA-mediated activation, but only dsRBD1 deletion reduced basal activity.
- Deletion of specific C-terminal residues near dsRBD2 significantly increased basal kinase activity, suggesting negative regulation.
- Heparin activated PKR mutants lacking dsRBDs, indicating alternative activation pathways.
Conclusions:
- PKR activity is regulated by multiple mechanisms, including the release of inhibition by negative-acting sequences.
- The dsRNA binding domains play a crucial role in PKR activation by dsRNA.
- Negative regulatory elements within PKR can be bypassed to enhance kinase activity.
Related Concept Videos
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
RNA Polymerase II Accessory Proteins
Regulation of the Unfolded Protein Response
RNA Polymerase II Accessory Proteins
PI3K/mTOR/AKT Signaling Pathway
Inhibitors of Viral Protein Synthesis

